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Abstract
Recent evidence indicates that the gut microbiota plays a key role in the
pathophysiology of obesity. Indeed, diet-induced obesity (DIO) has been
associated to substantial changes in gut microbiota composition in rodent models.
In the context of obesity, enhanced adiposity is accompanied by low-grade
inflammation of this tissue but the exact link with gut microbial community remains
unknown. In this report, we studied the consequences of high-fat diet (HFD)
administration on metabolic parameters and gut microbiota composition over
different periods of time. We found that Akkermansia muciniphila abundance was
strongly and negatively affected by age and HFD feeding and to a lower extend
Bilophila wadsworthia was the only taxa following an opposite trend. Different
approaches, including multifactorial analysis, showed that these changes in
Akkermansia muciniphila were robustly correlated with the expression of lipid
metabolism and inflammation markers in adipose tissue, as well as sever...
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Akkermansia muciniphila inversely 
correlates with the onset of 
inflammation, altered adipose 
tissue metabolism and metabolic 
disorders during obesity in mice
Marc Schneeberger1,2,3,*, Amandine Everard4*, Alicia G. Gómez-Valadés1,3, 
Sébastien Matamoros4, Sara Ramírez1, Nathalie M. Delzenne4, Ramon Gomis1,2,3,  
Marc Claret1,3# & Patrice D. Cani4#
Recent evidence indicates that the gut microbiota plays a key role in the pathophysiology of obesity. 
Indeed, diet-induced obesity (DIO) has been associated to substantial changes in gut microbiota 
composition in rodent models. In the context of obesity, enhanced adiposity is accompanied by 
low-grade inflammation of this tissue but the exact link with gut microbial community remains 
unknown. In this report, we studied the consequences of high-fat diet (HFD) administration on 
metabolic parameters and gut microbiota composition over different periods of time. We found that 
Akkermansia muciniphila abundance was strongly and negatively affected by age and HFD feeding 
and to a lower extend Bilophila wadsworthia was the only taxa following an opposite trend. Different 
approaches, including multifactorial analysis, showed that these changes in Akkermansia muciniphila 
were robustly correlated with the expression of lipid metabolism and inflammation markers in 
adipose tissue, as well as several circulating parameters (i.e., glucose, insulin, triglycerides, leptin) 
from DIO mice. Thus, our data shows the existence of a link between gut Akkermansia muciniphila 
abundance and adipose tissue homeostasis on the onset of obesity, thus reinforcing the beneficial 
role of this bacterium on metabolism.
The digestive tract is colonized by trillions of microbes (i.e., the gut microbiota) that exert a wide range of 
beneficial functions for the host. In recent years, it has become apparent that alterations in gut microbiota 
composition is associated with the development of highly prevalent metabolic disorders such as obesity 
and type 2 diabetes (T2D) in both animal and human studies1–7. We and others have demonstrated 
that high-fat diet (HFD) feeding profoundly affects the gut microbial community1,8–14. In particular, the 
abundance of Bifidobacterium spp. and Akkermansia muciniphila is consistently reduced under HFD 
regimen8,14,15. We also observed a decrease in Lactobacillus spp. and Bacteroides/Prevotella spp. However, 
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the reduced abundance of these genera was less consistent16–18 suggesting that these changes were not 
involved in the development of the disorders associated with diet-induced obesity (DIO). Recently, 
increased abundance of Bilophila wadsworthia has been associated with fat feeding and inflammation7,19.
The pathological massive expansion of adipose tissue in obesity states is associated with the devel-
opment of low-grade inflammation, which is reflected by enhanced production of cytokines, chemok-
ines and pro-inflammatory fatty acids. This causes an imbalance between pro- and anti-inflammatory 
factors produced by leukocytes, further promoting inflammation and adipose tissue dysfunction (e.g., 
β -oxidation, browning processes, adipogenesis)20–23. Despite the well-established link between DIO and 
gut microbiota alterations, it is currently unknown whether changes in the abundance of specific bacte-
ria precedes or remains present during the development of obesity and related adipose tissue metabolic 
alterations.
In the current study we explored the potential interconnection between adipose tissue inflammation/
function and changes in specific microbes during obesity and T2D development following chronic HFD 
feeding in mice. Our results demonstrate specific changes in gut bacteria over the progress of obesity, 
together with a robust negative association between Akkermansia muciniphila and inflammation and a 
positive association with adipose tissue browning process markers. This work also demonstrates that 
this bacterium declines before the onset of metabolic alterations, thereby suggesting a putative causative 
implication in the disease progression.
Results
Body weight and adiposity progression over 16 weeks of HFD feeding. It is well established 
that HFD feeding promotes weight gain and adiposity leading to obesity. Here we found that HFD 
administration modestly, but significantly, increased body weight and adiposity after 3 and 6 weeks of 
dietary treatment. However, after this time point, we found a major effect of the diet on body weight 
gain, which rose up to ~ 45% after 12–16 weeks as compared to only ~ 15% after 6 weeks of treatment 
(Fig. 1A). Adiposity followed a similar pattern, with a dramatic increase at 12 weeks of age (~ 3.5 fold) 
as compared to control diet (CT) mice. This effect was even more pronounced after 16 weeks of HFD 
Figure 1. Kinetic evolution of body weight and adiposity following chronic HFD administration. (A) Body 
weight gain (g) and (B) adiposity (% of eWAT on total body weight) measured after 3 weeks (3w); 6 weeks 
(6w); 12 weeks (12w) and 16 weeks (16w) of a high-fat diet (HFD) or a control diet (CT) (n = 6/group). Data 
are presented as the mean ± SEM. Data are significantly different (P < 0.05) according to the unpaired  
two-tailed Student t-test. *indicates a significant difference versus CT (P < 0.05).
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feeding (Fig.  1B). Collectively, these results indicate that the greatest impact on body weight gain and 
adiposity in mice occurs after 6 consecutive weeks of HFD administration.
Markers of adipose tissue metabolism and inflammation were altered after HFD adminis-
tration. We next assessed the repercussion of chronic HFD feeding on adipose tissue metabolism by 
measuring several markers of metabolic inflammation (Tnf, Ccl2, Itgax, Emr1, Lbp, Il6, Il1), fatty acid 
oxidation (Acox1, Cpt1a, Acacb), fat browning (Cidea, Ppargc1a, Ppargc1b, Elovl3, Prdm16), lipogenesis 
(Dgat2, Fasn, Acaca) and adipogenesis (Pparg and Cebpa) by quantitative PCR (qPCR). Macrophage infil-
tration markers (Itgax and Emr1) and recruitment of immune cells (Ccl2) were significantly increased as 
early as 3-weeks after the beginning of the HFD treatment (Fig. 2B–D), whereas markers of inflammation 
such as Tnfa and Lbp exhibited a trend to be increased but did not reach significance (Fig. 2A,E). After 
12 weeks of HFD, all the aforementioned markers were strongly and significantly increased. Both Il6 and 
Il1 mRNA expression were not significantly affected by the treatment (Fig. 2F,G).
Among the different markers of lipid metabolism involved in oxidation and browning program in 
white adipose tissue, we found that Ppargc1a, Cidea, and Acacb mRNA expression levels were signif-
icantly decreased after only 3 weeks of HFD (Fig.  3A,E,D), whereas other key markers of β -oxidation 
(Acox1) were not affected (Fig.  3H). Ppargc1a, Ppargc1b and Acacb transcript expression was dramat-
ically decreased after 12 weeks of HFD and remained lower until the end of the dietary intervention 
(Fig. 3A–D). Cpt1a was slightly but significantly increased after 3, 6 and 12 weeks of treatment (Fig. 3C). 
Elovl3 and Prdm16 mRNA expression levels were not affected by HFD throughout the experimental 
period.
Dgat2 expression, the enzyme that catalyzes the final step in triglyceride synthesis, was increased after 
3 weeks of HFD and remained high during the overall period of time (Fig. 4A). Markers of lipogenesis 
were inversely affected by the HFD, while Fasn mRNA expression increased, Acaca transcript expres-
sion decreased after 16 weeks of dietary intervention (Fig. 4B,C). Ppparg and Cebpa mRNA expression 
levels, both markers of adipocyte differentiation, showed marginal changes over the course of the diet 
(Fig. 4D,E).
Collectively, the gene expression changes observed in white adipose tissue indicate that HFD admin-
istration causes profound changes in key genes implicated in inflammation, fatty acid oxidation and 
lipogenesis. Minimal effects were observed on genes mediating adipocyte browning and differentiation. 
In general, and in line with the physiological results, the most obvious alterations in gene expression were 
recorded after prolonged HFD treatments.
Evolution of regulatory markers of food intake, diabetes and adiposity over 16 weeks of 
HFD. Defective energy balance is a major feature occurring during obesity. Energy balance is finely 
regulated by interactions between peripheral tissues, such as the intestine, and the central nervous sys-
tem. In the hypothalamus, neuropeptide Y (NPY) and Agouti-related protein (AgRP) are orexigenic 
peptides, whereas proopiomelanocortin (POMC) precursor protein is cleaved into anorexigenic peptides. 
Interestingly, alterations in the expression of these neuropeptides have been extensively reported during 
HFD. Moreover, gut microbiota has recently been shown to be able to influence the expression of these 
neuropeptides in the hypothalamic arcuate nucleus of mice24. Therefore, we measured these parameters 
in our study. We found a decrease in the expression of orexigenic peptides such as AgRP during HFD, 
whereas the expression of anorexigenic peptides (POMC) were increased (at all studied time points) 
(Fig. 5A and C). Aging did not seem to impact on the expression of AgRP, NPY or POMC in the hypo-
thalamus (Fig.  5A–C). We also found that markers of insulin resistance, such as fasted glycemia and 
insulinemia, progressively increased during prolonged HFD treatment. A similar trend was observed for 
both triglyceridemia and leptin levels (Fig. 5D–C).
Evolution of selected gut bacteria during HFD feeding. Based on previous findings8,14–18, we 
measured the abundance of selected bacteria during the progress of HFD administration. We found that 
Akkermansia muciniphila, Bifidobacterium spp. and Lactobacillus spp. were significantly decreased after 
3 and 6 weeks on HFD, although this decrease was transient for Bifidobacterium spp. and Lactobacillus 
spp. (Fig.  6A,B,D). The abundance of Akkermansia muciniphila decreased gradually to finally reach a 
level ~ 10,000 times lower than the initial one. Remarkably, under control diet, the levels of Akkermansia 
muciniphila progressively decreased by ~ 100 times as compared to young CT mice. Among the different 
bacteria the effect of aging was observed only for this taxon (Fig. 6A). We also observed that the abun-
dance of Roseburia spp. and the abundance of Bilophila wadsworthia increased after 12 and 16 weeks 
of HFD treatment (Fig. 6C,F). Interestingly, the abundance of Bilophila wadsworthia was unaffected or 
even decreased during earlier time points of HFD (Fig.  6F). Both Bacteroides/Prevotella spp. and total 
bacteria were affected by the treatment at 6 and 12 weeks of age but were similar between groups at the 
end of the experimental period (Fig.  5E,F). Thus these data confirm that HFD feeding affects specific 
gut bacteria, and highlight that the abundance of Akkermansia muciniphila progressively decline with 
prolonged dietary treatment in CT mice, and that this effect is exacerbated upon HFD.
Multifactorial analysis of adipose tissue markers and bacteria. In order to identify puta-
tive markers driving the modulation of metabolism in older animals and/or during HFD-feeding, we 
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Figure 2. Time series evolution of markers of inflammation and macrophage infiltration in white adipose 
tissue following HFD administration. mRNA expression of (A) Tnf (encoding TNF-α ), (B) Ccl2 (encoding 
MCP-1), (C) Itgax encoding CD11c), (D) Emr1 (encoding F4/80), (E) Lbp (encoding LBP), (F) Il6 (encoding 
Il-6) and (G) Il1b (encoding IL-1β ) measured in the adipose tissue after 3 weeks (3w); 6 weeks (6w); 12 weeks 
(12w) and 16 weeks (16w) of a high-fat diet (HFD) or a control diet (CT) (n = 6/group). Data are presented 
as the mean ± SEM. Data are significantly different (P < 0.05) according to the unpaired two-tailed Student 
t-test. *indicates a significant difference versus CT (P < 0.05).
www.nature.com/scientificreports/
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Figure 3. Time series evolution of markers of fatty acid oxidation and browning in white adipose 
tissue following HFD treatment. mRNA expression of (A) Pppargc1a (encoding PGC1-α ), (B) Pppargc1b 
(encoding PGC1-β ), (C) Cpt1a (encoding CPT-1a), (D) Acacb (encoding ACC2), (E) Cidea (encoding 
CIDEA), (F) Elovl3 (encoding ELOVL3), (G) Prdm16 (encoding PRDM16) and (H) Acox1 (encoding 
ACOX1) measured in the adipose tissue after 3 weeks (3w); 6 weeks (6w); 12 weeks (12w) and 16 weeks 
(16w) of a high-fat diet (HFD) or a control diet (CT) (n = 6/group). Data are presented as the mean ± SEM. 
Data are significantly different (P < 0.05) according to the unpaired two-tailed Student t-test. *indicates a 
significant difference versus CT (P < 0.05).
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combined the bacterial taxa and metabolic parameters obtained at each time point in a multifactorial 
analysis. This multifactorial analysis takes into account all the different parameters measured in this 
study for each mouse, and allows us to determine if mice from the same group cluster together accord-
ing to these metabolic parameters, thereby suggesting that altogether these parameters are key factors 
affected by age and/or HFD-feeding. The individual factor map shows the distribution of the samples 
according to the multifactorial analyses results (Fig.  7). All the samples from week 3 were clustered 
together, whereas samples from week 6 were separated along axis 2 according to the diet. We found 
that samples from weeks 12 and 16 were all separated along axis 1 according to the dietary treatment, 
thereby confirming the major effect of the diet on all the parameters. CT samples from weeks 3, 6 and 
12 were all clustered together, while CT samples from week 16 were closer to the HFD samples from 
weeks 3 and 6. This observation suggests that older mice exhibit changes in the adipose tissue expression 
profile and microbiota composition similar to those observed during HFD at the early stage of obesity 
development (Fig. 7).
Figure 4. Time series evolution of markers of lipogenesis and adipogenesis in white adipose tissue 
following HFD treatment. mRNA expression of (A) Dgat2 (encoding DGAT2), (B) Acaca (encoding 
ACC1), (C) Fasn (encoding FAS), (D) Pparg (encoding PPAR-γ ) and (E) Cebpa (encoding CEBP-α ) 
measured in the adipose tissue after 3 weeks (3w); 6 weeks (6w); 12 weeks (12w) and 16 weeks (16w) of a 
high-fat diet (HFD) or a control diet (CT) (n = 6/group). Data are presented as the mean ± SEM. Data are 
significantly different (P < 0.05) according to the unpaired two-tailed Student t-test. *indicates a significant 
difference versus CT (P < 0.05).
www.nature.com/scientificreports/
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The hierarchical clustering is another way to illustrate the similarity and the clustering between differ-
ent samples. The smaller the distances (resulting from the addition of horizontal distances in dark line) 
linking samples are, the higher is the similarity for the parameters measured. The hierarchical clustering 
(Fig.  8) shows that HFD samples from weeks 12 and 16 grouped distant from the other samples. In 
addition, this graphical representation showed a robust clustering of CT samples from week 16 with HFD 
samples from week 6, emphasizing again putative similarities between HFD and aging. CT samples from 
weeks 6 (HFD) and 12 (CT)clustered together, reinforcing the results obtained with the individual factor 
map (Fig. 7).
Akkermansia muciniphila strongly correlates with adipose tissue metabolic parameters. To 
further explore whether one specific bacterial taxa was correlated with host metabolism markers, we 
performed a multifactorial correlation circle and correlation map. This analysis is taking into account all 
the parameters measured in the study and determine if specific parameters are influencing or correlat-
ing with the others. It allows to determine the strength of the relation between the different parameters 
measured in the study. When the arrows are pointing in the same direction, this demonstrates that the 
parameters are positively correlated. If the arrows are pointing in opposite directions, the parameters are 
inversely correlated. When they are indicating different directions, this means that the parameters are not 
Figure 5. Time series evolution of orexigenic and anorexigenic markers in the hypothalamus and 
circulating levels of metabolic parameters following HFD treatment. mRNA expression of (A) AgRP 
(encoding AGRP), (B) Npy (encoding NPY), (C) Pomc (encoding POMC) measured in the hypothalamus,. 
Circulating levels of (D) glucose, (E) triglycerides, (F) leptin and (G) insulin measured in the serum of mice 
after 3 weeks (3w); 6 weeks (6w); 12 weeks (12w) and 16 weeks (16w) of a high-fat diet (HFD) or a control 
diet (CT) (n = 6/group). Data are presented as the mean ± SEM. Data are significantly different (P < 0.05) 
according to the unpaired two-tailed Student t-test. *indicates a significant difference versus CT (P < 0.05).
www.nature.com/scientificreports/
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evolving in the same way and are likely not correlated. It is also important to mention that the length of 
the arrows is an indicator of the strength of the correlation.
Surprisingly, we found that the levels of Akkermansia muciniphila were strongly and positively cor-
related with the levels of almost all the parameters involved in fatty acid oxidation and fat browning 
(Fig.  9A). Conversely, the levels of Akkermansia muciniphila were inversely associated with inflamma-
tory markers, lipid synthesis, and several plasma markers of insulin resistance, cardiovascular risk and 
adiposity (Fig. 9A). Bifidobacterium spp. tended to exhibit a similar pattern as Akkermansia muciniphila, 
whereas the other taxa were not associated with adipose tissue metabolic and inflammatory parameters, 
except the pathobiont Bilophila wadsworthia showing a moderate but opposite trend to Akkermansia 
muciniphila. Interestingly, most of the inflammatory factors were strongly correlated with axis 1 on the 
right side (Fig. 9A), which mainly represents the direction of older mice samples (i.e., prolonged treat-
ment time) as depicted in Fig. 7. Roseburia spp. tended to correlate moderately in this direction, while the 
other bacteria investigated were not associated with other parameters such as diet or aging (Figs 9A and 
7). These observations were further reinforced using another mathematical model (Fig. 9B). Akkermansia 
muciniphila was significantly and inversely correlated with 5 out of 7 inflammatory markers, all circulat-
ing parameters (i.e., insulin, glucose, triglycerides and leptin) and positively correlated with 118 out of 
Figure 6. Time series evolution of specific gut bacteria following HFD treatment. Quantification 
of (A) Akkermansia muciniphila, (B) Bifidobacterium spp., (C) Roseburia spp. (D) Lactobacillus spp., 
(E) Bacteroides/Prevotella spp, (F) Bilophila wadsworthia and (G) total gut bacteria abundance after 3 weeks 
(3w); 6 weeks (6w); 12 weeks (12w) and 16 weeks (16w) of a high-fat diet (HFD) or a control diet (CT) and 
expressed as Log cells per g of caecal content (n = 6/group). Data are presented as the mean ± SEM. Data are 
significantly different (P < 0.05) according to the unpaired two-tailed Student t-test. *indicates a significant 
difference versus CT (P < 0.05).
www.nature.com/scientificreports/
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13 genes involved in fatty oxidation, synthesis and browning, while Bifidobacterium spp. abundance was 
significantly and negatively correlated with 3 inflammatory markers, and leptin and positively correlated 
with only 2 gene involved in fatty oxidation. However, Bilophila wadsworthia points in an opposite direc-
tion than Akkermansia muciniphila. Although not fully correlated with the same parameters, Bilophila 
wadsworthia was positively associated with 4 out of 7 inflammatory markers, and negatively associated 
with 7 out of 13 genes involved in fatty oxidation, synthesis and browning and positively with 3 plasma 
parameters (i.e., insulin, triglycerides and leptin).
Discussion
In the present study, we used targeted approaches to investigate the impact of HFD on specific gut 
bacteria abundance and metabolic parameters. Importantly, we focused our adipose tissue metabolic 
analysis on epididymal fat since this fat depot is an appropriate surrogate of whole-body white adipose 
tissue. This fat pad is particularly increased after HFD administration when compared to mesenteric 
Figure 7. Individuals factor map. The individual factor map presents the repartition of the samples (dots) 
in the multifactorial analysis’ plane. Time and diet (squares) are presented as illustrative (inactive) qualitative 
factors. Samples are colored according to treatment’s duration. Circles regroup all samples from a specific 
diet for a single time point, except week 3 where all samples are grouped together.
Figure 8. Hierarchical clustering. Hierarchical clustering of the samples on the principal components of 
the multifactorial analysis. This graph illustrates the similarities and the clustering between different samples. 
The smaller the distance linking samples is (resulting from the addition of horizontal distances in dark line), 
the more similar these samples are for the parameters measured.
www.nature.com/scientificreports/
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fat25. In addition, a detailed analysis of the general inflammatory response upon HFD administration 
shows an early and more dramatic activation of the inflammatory program in epididymal adipose tissue 
in comparison with mesenteric26. Moreover, by using this epididymal fat, we could investigate several 
important markers of inflammation, adipogenesis and browning, whereas this latter parameter does not 
occur in another visceral fat pad such as mesenteric fat for instance. The taxa we have selected are the 
most commonly studied, and corresponded to bacteria that have been previously associated with HFD 
feeding by using several culture-dependent and independent strategies1,7–9,13–15,17,19,27–30.
We found that changes in specific gut bacteria occur progressively following HFD feeding. In par-
ticular, Akkermansia muciniphila was linearly affected by the dietary treatment. By using a number of 
strategies, such as multifactorial analysis, we found a robust association between this bacterium and 
particular changes in adipose tissue inflammation and metabolic parameters. Among the 27 parameters 
measured, 20 of them were significantly (positively or negatively) correlated with Akkermansia muciniph-
ila (Fig. 9A,B). This suggests that this bacterium dialogue with host to maintain adequate adipose tissue 
metabolism and function, but this hypothesis warrants further direct investigation. Among all other 
bacteria measured in this study, Bilophila wadsworthia shows opposite trend with 14 of the 27 parameters 
significantly correlated with this bacterium. Bifidobacterium spp. has shown similar associations, but only 
few parameters (6 out of 20) were significantly correlated with this bacterium. Consistent with this, it has 
been reported a positive impact of Bifidobacterium spp. on metabolism during fat feeding31.
We have previously demonstrated lower levels of Akkermansia muciniphila in genetic obese (ob/
ob) mice and mice fed a HFD for up to 5 weeks1,14. Other recent reports also found that the abun-
dance of this bacterium is inversely associated with obesity and diabetes development following HFD 
administration15,28,32, thereby supporting our past and present findings. However, it is worth noting that 
recent studies have shown an increased abundance of Akkermansia muciniphila upon high fat and high 
Figure 9. Correlation circle and heat map correlation showing associations between bacterial taxa and 
adipose tissue metabolic parameters. Multifactorial analysis (A) correlation map and (B) heat map of 
the Spearman r correlations between the bacterial genera and the metabolic parameters measured in the 
adipose tissue of mice after 3 weeks (3w); 6 weeks (6w); 12 weeks (12w) and 16 weeks (16w) of a high-fat 
diet (HFD) or a CT diet (CT) (n = 6/group). Data are presented as the mean ± SEM. Squared cells depict 
significance following the Spearman correlation and FDR correction for multiple comparisons *P < 0.05.
www.nature.com/scientificreports/
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carbohydrate (sucrose, maltodextrin, corn starch) diet feeding33,34, thus the mechanisms promoting the 
bloom of Akkermansia muciniphila in these reports warrants further investigation. We recently discov-
ered that the composition of the fatty acids per se may also strongly contribute to the modulation of the 
abundance of Akkermansia muciniphila. We found that mice fed with a lard-enriched diet exhibited a 
significant decrease in Akkermansia muciniphila, whereas fish oil-enriched diet dramatically increased 
Akkermansia muciniphila in the gut and this effect was associated with a better control of the gut barrier 
function and lower adipose tissue inflammation, a phenomenon that can be transferred to germ-free 
recipient mice35.
Finally, another argument suggesting that Akkermansia muciniphila protects against body weight gain 
and adiposity development is based on studies showing that the simultaneous administration of HFD 
and Akkermansia muciniphila mitigated the impact of the diet in gut barrier dysfunction and body 
weight and fat mass gain14,28, although the underlying mechanisms are still unknown.
We found important variations of Akkermansia muciniphila quantity with for instance a 100-fold 
reduction over the period studied, however, the magnitude of the difference observed between inflamma-
tory markers was not following the same trend. Although one would have expected a linear relationship, 
that is less Akkermansia corresponds to more inflammation, the present study as well as previous studies 
does not support the idea that such simple and strict linear relationship exists14,28,36,37. Thus, although we 
still do not know exactly the levels required to observe a shift between a healthy versus a pathological 
situation, it is likely that below a certain level (i.e., a threshold) of Akkermansia muciniphila gut barrier 
function and other physiological parameters (e.g., altered adipogenesis/browning) become altered. In 
accordance with this hypothesis, we have recently demonstrated in human that below a given quantity 
of Akkermansia muciniphila, subjects were less prone to positively respond to caloric restriction diet 
in terms of the improvement of inflammatory markers, insulin resistance and glycemia. Therefore, we 
do not rule out that the decrease in Akkermansia muciniphila observed in older mice in this study was 
not enough to reach the threshold level of Akkermansia muciniphila for inducing strong inflammatory 
markers and diabetes.
We have also revealed a link between Akkermansia muciniphila and age, since the intestinal levels 
of this bacterium also declined with age upon CT diet feeding. Interestingly, HFD strongly influenced 
adipose tissue profile and intestinal microbiota in a way that mimicked aging, or at least older mice. 
For example, young HFD fed mice (6 weeks of HFD) were clustered with older CT mice (12 weeks 
of diet). Moreover, older CT samples (16 weeks) displayed an intermediate state between young and 
long-term HFD samples. In humans, it has also been suggested that Akkermansia muciniphila progres-
sively decreases in elderly subjects38, thereby corroborating our findings. Taken together, our results 
indicate that HFD administration is an aggravating factor of age, although we did not further investigate 
this question in mice followed throughout their entire lifespan.
Although previous studies have found a putative link between caloric intake and the abundance of 
Akkermansia muciniphila39,40, we did not found any relationship between this taxa and markers of hypo-
thalamic control of food intake. Since HFD diet is associated with an increase in calorie intake, the 
decreased expression of orexigenic peptides (AgRP) during HFD coupled with the increased expression 
of anorexigenic peptides (POMC) (at all studied time points) in the hypothalamus strongly suggest a 
resistance to negative feedback usually associated with ingestion of caloric rich diet as reported in the 
literature41. The available literature shows a significant variability and inconsistencies in neuropeptide 
expression upon HFD administration. This is likely the consequence of the rodent strain used, the per-
centage of fat in the diet and the length of diet exposure. Nevertheless, our results are in accordance 
with the accepted general idea that HFD reduces orexigenic NPY and AgRP expression while increases 
POMC levels41.
In conclusion, our data show that diet-induced metabolic disorders in mice progressively develop with 
time reaching a maximal impact after 12 weeks of treatment. Moreover, the abundance of specific taxa, 
such as Bifidobacterium spp. and Akkermansia muciniphila, were strongly associated with markers of lipid 
metabolism and negatively associated with inflammation in adipose tissue, circulating glucose, leptin, 
triglycerides and insulin. Although both bacteria are early affected by the HFD treatment, Akkermansia 
muciniphila levels robustly decreased in a sustained manner until the end of the experimental period. This 
effect was also present during CT diet feeding, thereby suggesting the impact of age on this bacterium, 
since Bilophila wadsworthia that correlates with metabolic parameters was mainly affected after a prolonged 
dietary intervention (i.e., 12 to 16 weeks of HFD). Thus, although future studies are required to decipher 
the mechanisms underlying the rapid decline of Akkermansia muciniphila during HFD and aging, our data 
reinforce the putative beneficial impact of this bacterium on metabolism and the need of investigating its 
role in humans on the development of metabolic disorders associated with fat feeding and aging.
Methods
Mice and diets. Male age-matched C57BL/6J mice were purchased from Harlan Europe. Mice were 
maintained on a 12:12h light–dark cycle with free access to water and standard chow (Harlan Research 
Laboratories) or high-fat diet (45% Kcal from fat; Research Diets) for 3, 6, 12 and 16 consecutive weeks 
(starting at 6 weeks of age). All experimental groups were maintained and studied in parallel to minimize 
environmental effects. The whole study included n = 6 mice/diet/time point. Body weights were weekly 
determined. Mice were overnight fasted and culled by cervical dislocation. The entire epididydmal fat 
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was carefully dissected and tissues (blood, fat, hypothalamus and caecal content) were rapidly snapped 
frozen in liquid nitrogen. To avoid potential variations between groups, tissues from mice fed with stand-
ard or HFD were alternately dissected. Mice from only one time-point were processed per day. Adiposity 
was measured by weighting the epididymal fat depot normalized by body weight. All in vivo studies 
were performed with approval of the University of Barcelona Ethics Committee, complying with current 
Spanish and European legislation.
Quantitative PCR analysis of gene expression. Tissue mRNA isolated using Trizol (Invitrogen) 
following standard protocols. Total RNA was quantified using a NanoDrop spectrophotometer and 
cDNA generated using Taqman High-capacity Retrotranscription kit (Applied Biosystems). Quantitative 
PCR (qPCR) was performed as previously described42. Relative gene expression was calculated using 
the standard curve method. Proprietary Taqman Gene Expression assay FAM/TAMRA primers used 
(Applied Biosystems) were: Acetyl-CoA carboxylase 1 (Acaca; Mm01304257m1), Acetyl-CoA carbox-
ylase 2 (Acacb; Mm01204671m1), Peroxisomal acyl-coenzyme A oxidase 1 (Acox; Mm01246834m1), 
chemokine (C-C motif) ligand 2 (Ccl2; Mm00441242m1), CCAAT/enhancer-binding protein alpha 
(Cebpa; Mm00514283s1), Cell death activator (Cidea; Mm00432554m1), carnitine palmitoyltrans-
ferase 1A (Cpt1a; Mm01231183m1), Diglyceride acyltransferase (Dgat2; Mm00499536m1), Fatty Acid 
Elongase 3 (Elovl3; Mm00468164m1), EGF-like module-containing mucin-like hormone receptor-like 
1 (Emr1; Mm00802529m1), Fatty acid synthase (Fasn; Mm00662319m1), Interleukin-1 beta (Il1b; 
Mm00434228m1), Interleukin-6 (Il6; Mm00446190m1), Integrin alpha X (Itgax; Mm00498698m1), 
Lipopolysaccharide binding protein (Lbp; Mm00493139m1), Peroxisome proliferator-activated receptor 
gamma (Pparg; Mm01184322m1), Peroxisome proliferator-activated receptor gamma coactivator 1-alpha 
(Ppargc1a; Mm01208835m1), Peroxisome proliferator-activated receptor gamma coactivator 1-beta 
(Ppargc1b; Mm00504720m1), PR domain containing 16 (Prdm16; Mm00712556m1), tumor necrosis 
factor alpha (Tnfa; Mm00443258m1), Agouti-related peptide (agrp; Mm00475829g1), Neuropeptide Y 
(npy; Mm00445771m1) and pro-opiomelanocortin (pomc; Mm00435874m1). Hypoxanthine-guanine 
phosphoribosyltransferase (Hprt; Mm01545399m1) was used as housekeeping gene. mRNA levels were 
measured using the ABI Prism 7900 HT system (Applied Biosystems).
Gut microbiota qPCR quantification. Metagenomic DNA was extracted from the caecal con-
tent using a QIAamp-DNA stool mini-kit (Qiagen, Hilden, Germany) according to the manufactur-
er’s instructions and the adapted procedure previously described43. The primers and probes used 
to detect the different bacteria were based on 16S rRNA gene sequences: Total Bacteria (Bacteria 
Universal) F-ACTCCTACGGGAGGCAGCAG, R-ATTACCGCGGCTGCTGG; Bifidobacterium spp. 
F-TCGCGTCYGGTGTGAAAG, Bifidobacterium spp. R-CCACATCCAGCRTCCAC, Lactobacillus spp. 
F-CCTTTCTAAGGAAGCGAAGGAT, and Lactobacillus spp. R-AATTCTCTTCTCGGTCGCTCTA; 
Bacteroides-Prevotella spp. F-CCTTTCTAAGGAGCGAAGGAT, Bacteroides-Prevotella spp. R- AATTCT 
CTTCTCGGTCGCTCTA; Akkermansia muciniphila F-CAGCACGTGAAGGTGGGGAC, Akkermansia 
muciniphila R-CCTTGCGGTTGGCTTCAGAT; Roseburia spp. F-AAGCGACGATCAGTAGCCGA, 
Roseburia spp. R-.TTCTTCTTCCCTGCTGATAGAG; Bilophila wadsworthia F-, 
ACCCTGGTAGTCCACGCTGT Bilophila wadsworthia R- TGAGTTCAGCCTTGCGACCG; Detection 
was achieved with a STEP one PLUS instrument and software (Applied Biosystems, Foster City, CA, 
USA) using MESA FAST qPCR MasterMix Plus for SYBR Assay (Eurogentec, Verviers, Belgium). Each 
assay was performed in duplicate in the same run. The cycle threshold of each sample was then compared 
to a standard curve (performed in triplicate) made by diluting genomic DNA (five-fold serial dilution) 
(BCCM/LMG, Ghent, Belgium and DSMZ, Braunshweig, Germany). The data were expressed as Log 
bacteria/g of cecal content as described in Everard et al.14.
Statistical analysis. Data are expressed as means ± s.e.m. Differences between two groups were 
assessed using the unpaired two-tailed Student’s t-test. Data were analysed using GraphPad Prism ver-
sion 5.00 for Windows (GraphPad Software, San Diego, CA, USA). Data related to the gut microbiota 
were analysed using JMP 8.0.1 (SAS Institute, Inc., Cary, NC) and R 3.0.2 (The R Foundation) with the 
RStudio 0.97.310 packages and gplots for the heatmap. Multifactorial analysis was performed using the 
FactoMineR 1.28 package for R (FactoMineR: an R package for multivariate analysis). The results were 
considered statistically significant at P < 0.05. False Discovery Rate (FDR) corrections for multiple com-
parisons were performed according to the Benjamini Hochberg procedure44.
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